Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis.
CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
The obesity-related pathology and Th17 cells.
Leuprolide Acetate Inhibits Spinal Cord Inflammatory Response in Experimental Autoimmune Encephalomyelitis by Suppressing NF-x03BA;B Activation.
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
A framework for optimal whole-sample histological quantification of neurite orientation dispersion in the human spinal cord.
Pediatric multiple sclerosis: Escalation and emerging treatments.
Age-Related Uptake of Heavy Metals in Human Spinal Interneurons.
Social cognition in multiple sclerosis: A systematic review and meta-analysis.
Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
Ectopic Lymphoid Structures: Powerhouse of Autoimmunity.
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
Ophthalmologic aspects of chikungunya infection.
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis.
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.
Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome.
The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Pages
« first
‹ previous
…
773
774
775
776
777
778
779
780
781
…
next ›
last »